Search results
Showing 1 to 3 of 3 results for dinutuximab
syndrome - azacitidine 1 June 2010 TBC Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) 30 September 2016 TA494...
Evidence-based recommendations on dinutuximab beta (Qarziba) for high-risk neuroblastoma in people aged 12 months and over.
Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]
Discontinued [GID-TAG507]